Peer-reviewed Publications

2026

  1. Ron Fisher, Ou Yang, Susan Mendez, Jongsay Yong, Yuting Zhang, Karinna Saxby. Patient Characteristics and Primary Care Enrolment: The Case of Australia’s MyMedicare. The Australian Economic Review. Accepted Aug 17, 2026. (ABDC B) (forthcoming)
  2. Yingbei Xiong, Changli Jia, Yifan Yao, Tianqin Xue, Yuting Zhang*, Li Xiang*. Identifying payment-driven patient selection using machine-learning-predicted cost risk: evidence from neonatal care in China. BMC Medicine. Aug 6 2026. (Scopus Equivalence A*) DOI
  3. Henry Cutler, Anthony Scott, Rosalie Viney, Yuting Zhang, Kees van Gool, Kim Dalziel, Jane Hall, Julie Ratcliffe. Better ways to improve care economy productivity in Australia. Australian and New Zealand Journal of Public Health (accepted 16 July 2026) (Scopus Equivalence A) (forthcoming)
  4. Ou Yang, Ron Fisher, Karinna Saxby, Jongsay Yong, Yuting Zhang. Beyond Inflation: The Adequacy of Out of Home Care Allowances in Australia. The Australian Economic Review. July 2, 2026. (ABDC B) PDF
  5. Weizhuo Chen, Changli Jia, Yuting Zhang, Qiao Yang, Sisi Zhong, Junyi Chen, and Ting Ye*. Patient-Physician Ethnic Concordance and its Impact on Care Continuity: First Evidence from Tibet. Journal of Racial and Ethnic Health Disparities. 13 March 2026. (Scopus Equivalence A*) PDF
  6. Yuting Zhang, Stephen Duckett, Charles Kemp. Australia’s specialist fee failure: three principles for a way forward. The Australian Economic Review. 26 Feb 2026. [ABDC B] DOI
  7. Caixuan Xie, Yuting Zhang, Lei Zhu, Guanyang Zou. Association Between Sleep Duration and Intrinsic Capacity in Older Adults: Evidence from a Longitudinal Cohort Study and Bayesian Network Analyses. BMC Geriatrics. Published 17 February 2026. (Scopus Equivalence A) PDF
  8. Karinna Saxby, Chenhao Liang, Kerry Hall, Mike Stephens, Yuting Zhang, and Amal N. Trivedi. Medication Use in Indigenous and Other Australians After a Pharmaceutical Copayment Subsidy. JAMA Health Forum. Published 6 March 2026. (Scopus Equivalence A*) PDF

2025

  1. Zhixin Fan, Yuting Zhang, Yibo Wu, Jia Yin, Qiang Sun. Public Understanding and Misuse of Antibiotics in China: Insights from a Comprehensive National Survey. The Lancet Regional Health - Western Pacific. Sept 15 2025. (Scopus Equivalence A*) DOI
  2. Federico Zilio, Ross Hickey, Ted McDonald, Eric Sun, Yuting Zhang. Health shocks and household allocation of time and spending. Review of Economics of the Household. (online first Sept 7, 2025): (Scopus Equivalence A*) DOI
  3. Karinna Saxby and Yuting Zhang. Do rurality-based financial incentives improve equity of primary healthcare access? Evidence from Australia. Health Economics. 18 June 2025 [ABDC A*] DOI
  4. Chenxi Li, Yushu Liu, Jianing Zheng, Xi Wang, Yuting Zhang, John Fu, Wenwen Yu, Ting Yu, Dan Wang*, Chaojie Liu*. Potential to Perpetuate Social Biases in Health Care by Chinese Large Language Models: A Model Evaluation Study. International Journal for Equity in Health. July 15 2025. (Scopus Equivalence A) PDF
  5. Hangjing Zhang; Xuan Zhu; Yuting Zhang, and Juyang Xiong*. Factors Influencing HIV Testing Choices Among Chinese Undergraduates: Insights from a Discrete Choice Experiment. BMC Public Health. June 2025. (Scopus Equivalence A) PDF
  6. Xuan Zhu, He Ma, Hangjing Zhang, Yuting Zhang, Juyang Xiong*. Dynamic cross-lagged effects between healthy lifestyles and multimorbidity among middle-aged and older adults in China. BMC Public Health. 7 June 2025. (Scopus Equivalence A) PDF
  7. Scott Barkowski, Dajung Jun, and Yuting Zhang. Spillover Effects of Medicaid Expansion on Medicare: Evidence from Administrative Data. Journal of Policy Analysis and Management. 2025. 44 (2), 579-611 [ABDC A] DOI
  8. Ou Yang and Yuting Zhang*. Waiting times for psychiatric specialist services in Australia. JAMA Network Open 2025;8(2):e2461947. (Feb 26 2025 online). (Scopus Equivalence A*) PDF
  9. Karinna Saxby and Yuting Zhang. Geographic variation in bulk billing rates and out-of-pocket costs for General Practitioner services: evidence from whole-of-population Medicare data. Medical Journal of Australia. Feb 17 2025; Online first: (Scopus Equivalence A*) DOI

2024

  1. Øyvind Snilsberg, Tor Iversen, Anne Karen Jenum, and Yuting Zhang. Effects of a national checklist on recommended procedures among patients with type 2 diabetes. BMC Health Services Research 24, 1472 (Nov 26 2024). (Scopus Equivalence A) PDF
  2. Ou Yang, Yuting Zhang, Yat Hang To, Maarten IJzerman, Judith Liu, Sallie Pearson, Karen Trapani, Fanny Franchini, and PRIMCAT group. Effects of clinical and socioeconomic factors on Medicare and patient costs for colorectal cancer in Australia: a retrospective multivariate regression analysis. BMJ Open; 2024 Dec 9;14(12):e081483. (Scopus Equivalence A) PDF
  3. Karinna Saxby, Zeo Aitken, Luke Burnchill, and Yuting Zhang. Community attitudes and Indigenous Health Disparities: Evidence from Australia’s Voice Referendum. The Lancet Regional Health - Western Pacific. Online first Aug 2 2024. (Scopus Equivalence A*) DOI
  4. Karinna Saxby, Yuting Zhang, and Zoe Aitken. Structural stigma and sexual orientation disparities in long-term health conditions: Evidence from the Australian Census. American Journal of Public Health; online first Aug 2 2024; 2024:e1–e13. [ABDC A*] DOI
  5. Jie Chang, Shan Zhu, Yuting Zhang, Natalie Carvalho, Sen Xu, Yunshu Lu, Miaomiao Xu, Chengzhou Tang, Xin Liu, Yu Fang, Qingyue Meng. Determinants of parental demand of HPV vaccination for adolescent daughters in China: Contingent valuation survey; International Journal of Health Planning and Management; Jul 17 2024; online first: (Scopus Equivalence A) DOI
  6. Yuting Zhang*, How can the Australian government make primary care and private health insurance more affordable? Australian Economic Review; May 14 2024; online first: [ABDC B] DOI
  7. Nathan Kettlewell, and Yuting Zhang. Financial incentives and private health insurance demand on the extensive and intensive margins. Journal of Health Economics. March 2024; Vol 94. [ABDC A*] DOI
  8. Ou Yang, Jongsay Young, and Yuting Zhang*, Effects of Private Health Insurance on Waiting Time in Public Hospitals. Health Economics. Jun 2024; 33(6): 1121-1411. Online first: [ABDC A*] DOI
  9. Nathan Kettlewell, Yuting Zhang*, Age penalties and take-up of private health insurance. Health Economics. Apr 2024; 33(4): 595-818; [ABDC A*] DOI

2023

  1. Judith Liu, Yuting Zhang*, Elderly responses to private health insurance incentives: evidence from Australia. Health Economics. Dec 2023; 32(12): 2673-2879. Among top 10 most cited paper published by the journal in 2023. [ABDC A*] DOI
  2. Judith Liu, Yuting Zhang*, Cameron Kaplan. Effects of Medicare Part D Coverage Gap Closure on Utilization of Branded and Generic Drugs. Health Economics. March 2023; Vol 32 (3): 539-743; online first: DOI: [ABDC A*] DOI

2022

  1. Judith Liu, Yuting Zhang*, Cameron Kaplan. Differential Effects by Mental Health Status of Filling the Medicare Part D Coverage Gap. Medical Care. 2022 Feb;60(2):133–139. (Scopus Equivalence A) DOI

2021

  1. Jongsay Yong, Ou Yang, Yuting Zhang, Anthony Scott. Ownership, Quality and Prices of Nursing Homes in Australia: Why Greater Private Sector Participation Did Not Improve Performance. Health Policy (available online first Sept 20 2021; [ABDC A as of 2020]) DOI
  2. Vicky Mengqi Qin, Yuting Zhang, Kee Seng Chia, Barbara McPake, Yang Zhao, Emily S G Hulse, Helena Legido-Quigley, John Tayu Lee. Temporal trends and variation in patient out-of-pocket health expenditures between 2011-2015: evidence from a Chinese national survey. International Journal for Equity in Health; June 19 2021. (Scopus Equivalence A) PDF
  3. Susan J. Méndez, Anthony Scott, Yuting Zhang. Gender differences in physician decisions to adopt new prescription drugs. Social Science & Medicine. April 4 2021 online first: (Scopus Equivalence A*) DOI
  4. Anthony Scott, Terence Bai, Yuting Zhang*. Association between telehealth use and General Practitioner characteristics during COVID-19: findings from a nationally representative survey of Australian doctors. BMJ Open Mar 25 2021;11(3). online (Scopus Equivalence A) DOI

2020

  1. Rishel C, Zhang Y, and Sun E. Association between Preoperative Benzodiazepine Use and Postoperative Opioid Use and Healthcare Costs. JAMA Network Open. 2020;3(10):e2018761. (Scopus Equivalence A*) PDF
  2. Meiqi He, James M. Stevenson, Yuting Zhang, and Inmaculada Hernandez. Risk Factors for Cardiovascular Events in Patients on Antidementia Medications, American Journal of Alzheimer’s Disease and Other Dementias. 2020. (Scopus Equivalence A) DOI
  3. Lanting Yang, Maria M. Brooks, Nancy W. Glynn, Yuting Zhang, Samir Saba, Inmaculada Hernandez. Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries with Atrial Fibrillation. The American Journal of Cardiology. 2020 Jul 1;126:29-36. Epub 2020 Apr 10 (Scopus Equivalence B) DOI
  4. Cade Shadbolt, Daniel Gould, Ximena Camacho, Josh Knight, Siddharth Rele, Yuting Zhang, Michelle Dowsey, and Peter Choong. Preoperative opioid use and complications following total joint replacement: A protocol for a systematic review and meta-analysis. BMJ Open. June 2020;10:e035377. (Scopus Equivalence A) PDF
  5. Cade Shadbolt, J Haxby Abbot, Ximena Camacho, Philip Clarke, L. Stefan Lohmander, Tim Spelman, Eric C. Sun, Jonas B. Thorlund, Yuting Zhang, Michelle M. Dowsey and Peter F.M. Choong. The Surgeon’s Role in the Opioid Crisis: A Narrative Review and Call to Action. 29 January 2020. Front. Surg. (Scopus Equivalence B) DOI

2019

  1. San-Juan-Rodriguez A, Zhang Y, He M, Hernandez I. Association of Antidementia Therapies with Time to Skilled Nursing Facility Admission and Cardiovascular Events among Elderly Adults with Alzheimer Disease. JAMA Network Open; March 2019;2(3):e190213. (Scopus Equivalence A*) PDF
  2. Zhang Y*, Mendez S, Scott A. Factors Affecting General Practitioners’ Decisions to Adopt New Prescription Drugs – Cohort Analyses Using Australian Longitudinal Physician Survey Data. BMC Health Services Research. Feb 2019; 19(1): 94. (Scopus Equivalence A) PDF

2018

  1. Zhang Y*, Baik SH, Zuvekas SH. Simulating Variation in Families’ Spending Across Marketplace Plans. Health Services Research. Aug 2018; 53(4). (ABDC ranked A; Scopus Equivalence A) DOI
  2. Hernandez I*, He M, Zhang Y. Comparing State, Regional, and Local Variation in Concurrent Opioid and Benzodiazepine Use. Drug and Alcohol Dependence. 2018 Oct 1;191:141-144. Epub 2018 Aug 7 (Scopus Equivalence A) DOI
  3. Hernandez I, He M, Brooks M, Zhang Y. Exposure-Response Association between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries. JAMA Network Open. June 2018;1(2):e180919. (Scopus Equivalence A*) DOI
  4. Cole Evan, Leighton Cassandra, Zhang Y. Distribution of Visits for Chronic Conditions Between Primary Care and Specialist Providers in Medicare Shared Savings Accountable Care Organizations. Medical Care. 2018 May;56(5):424-429. (Scopus Equivalence A) PDF
  5. Hernandez I*, Zhang Y, Saba S. Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin, Stratified by Stroke Risk in Patients with Atrial Fibrillation. American Journal of Cardiology. 2018 Jul 1;122(1):69-75. (Scopus Equivalence B) DOI
  6. Hospodar AR, Smith KJ, Zhang Y, Hernandez I. Comparing the Cost-effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants with Well-managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of Bleeding. Am J Cardiovasc Drugs. 2018 May 9. (Scopus Equivalence A) PDF
  7. Gray M, Saba S, Zhang Y, Hernandez I*. Outcomes of Atrial Fibrillation Patients Newly Recommended for Oral Anticoagulation under the 2014 AHA/ACC/HRS Guideline. Journal of the American Heart Association. 2018 Jan 4;7(1). pii: e007881. (Scopus Equivalence A) PDF

2017

  1. Hernandez I*, Zhang Y, Saba S. Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban and Warfarin in Newly Diagnosed Atrial Fibrillation. American Journal of Cardiology. 2017 Nov 15;120(10):1813-1819. (Scopus Equivalence B) DOI
  2. Hernandez I*, Zhang Y. Using predictive analytics and big data in optimizing pharmaceutical outcomes. American Journal of Health-System Pharmacy. 2017 Sep 15;74(18):1494-1500. (Scopus Equivalence A) DOI
  3. Hernandez I*, Saba S, Zhang Y. Geographical Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation. Stroke. 2017 Aug;48(8):2289-2291. (Scopus Equivalence A*; ) PDF
  4. Liu L, Zhang Y*. Does non-employment based health insurance promote entrepreneurship? Evidence from a policy experiment in China. Journal of Comparative Economics. May 2017. [ABDC A] DOI
  5. Hernandez I, Zhang Y*. Pharmaceutical Use and Spending Trend in Medicare Beneficiaries with Dementia, From 2006 to 2012. Gerontology and Geriatric Medicine. 2017 April. (Scopus Equivalence C) DOI
  6. Hernandez I, Zhang Y*. Comparing Adoption of Breakthrough and “Me-too” Drugs among Medicare Beneficiaries: A Case Study of Dipeptidyl Peptidase-4 Inhibitors. Journal of Pharmaceutical Innovation. Feb 2017. (Scopus Equivalence B) PDF
  7. Zhang Y, Tang W, Zhang Y, Liu L, Zhang L. Effects of Integrated Chronic Care Models on Hypertension Outcomes and Spending: a Multi-town Clustered Randomized Trial in China. BMC Public Health. 2017 Mar 11;17(1):244. (Scopus Equivalence A) PDF
  8. Zhang Y*, Hueser H, Hernandez I. Comparing the Approval and Coverage Decisions of New Oncology Drugs in the US and Other Selected Countries. Journal of Managed Care & Specialty Pharmacy. 2017 Feb;23(2):247-254. (Scopus Equivalence A) PDF
  9. Zhang Y*, Caines K, Powers CA. Evaluating the Effects of Pioneer Accountable Care Organizations on Medicare Part D Drug Spending and Utilization. Medical Care. Jan 2017. Online first: (Scopus Equivalence A) DOI
  10. Driessen J, Zhang Y. Trends in the Inclusion of Mental Health Providers in Medicare Shared Savings Program ACOs. Psychiatric Services. Jan 2017; online first: (Scopus Equivalence A) PDF
  11. Hernandez I, Zhang Y*, Brooks MM, Chin P, Saba S. Anticoagulation Use and Clinical Outcomes Following Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation. Stroke. 2017 Jan;48(1):159-166. (Scopus Equivalence A*) PDF

2016

  1. Hernandez I, Smith KJ, and Zhang Y*. Cost-Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation at High Risk of Bleeding. Thrombosis Research. Oct 2016; online first: (Scopus Equivalence A*) DOI
  2. Liu L, Svoboda R, Zhang Y*. Using a Modified Next Generation ACO Benchmark Can Improve the MSSP. American Journal of Accountable Care. September 14, 2016. Online first:. (Scopus Equivalence N/A) PDF
  3. Hernandez I, Zhang Y*. Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D Data. American Journal of Cardiovascular Drugs. September 2016; online first: (Scopus Equivalence A) PDF
  4. Driessen J, Baik S, Zhang Y. Trends in off-label use of second-generation antipsychotics in the Medicare population from 2006 to 2012. Psychiatric services. 2016 Aug 1;67(8):898-903. (Scopus Equivalence A) PDF
  5. Driessen J, Baik SH, Zhang Y. Explaining improved use of high-risk medications in Medicare between 2007 and 2011. Journal of the American Geriatrics Society. 2016 Apr 15; 64(3):674-6. PMC4806390. (Scopus Equivalence A) PDF
  6. Hou Z, Meng Q, Zhang Y. Hypertension Prevalence, Awareness, Treatment and Control Following China’s Health Care Reform. American Journal of Hypertension. 2016 Apr;29(4):428-31. (Scopus Equivalence A) DOI
  7. Baik S, Hernandez I, Zhang Y*. Evaluating the Initiation of Novel Oral Anticoagulants in Medicare Beneficiaries. Journal of Managed Care & Specialty Pharmacy. 2016 Mar;22(3):281-92. (Scopus Equivalence A) PDF
  8. Jarlenski M, Baik S, Zhang Y. Trends in use of medications for smoking cessation in Medicare Part D, 2007-2012. American Journal of Preventive Medicine. 2016 Mar 29. PMC4992646. (Scopus Equivalence A) DOI
  9. Zhang Y, Ma Q, Chen Y, Gao H. Effects of Public Hospital Reforms on Inpatient Expenditures in Rural China. Health Economics. 2016 Feb. (ABDC ranked A*; InCites 5-year; ranked 36/88 in Health Care Sciences & Services) DOI
  10. Kaplan CM, Zhang Y*. Anticipatory Behavior In Response To Medicare Part D’s Coverage Gap. Health Economics. 2016 Jan. (ABDC ranked A*) PDF

2015

  1. Zhang Y*, Talisa V, Baik S. Part D Plan Switching among Medicare Beneficiaries with Schizophrenia. Psychiatric Services. 2015 Oct; 66 (10):1105-1108. PMC4591078. (Scopus Equivalence A) PMC
  2. Hernandez I, Zhang Y*. Comparing Clinical and Economic Outcomes of Biologic and Conventional Medications in Postmenopausal Women with Osteoporosis. Journal of Evaluation in Clinical Practice. 2015 Oct; 21 (5):840-7. (Scopus Equivalence A) DOI
  3. Bellon JE, Stevans JM, Cohen S, James AE III, Reynolds B, Zhang Y. Comparing Advanced Practice Providers and Physicians as Providers of e-Visits. Telemedicine and e-Health. 2015 Jul 10. (Scopus Equivalence A) DOI
  4. Hernandez I, Zhang Y*. Risk of Bleeding with Dabigatran in 2010-2011 Medicare Data. JAMA Internal Medicine. 2015 Jul; 175 (7):1245-7. (Scopus Equivalence A*) DOI
  5. Hernandez I, Baik S, Pinera A, Zhang Y*. Risk of Bleeding With Dabigatran in Atrial Fibrillation. JAMA Internal Medicine. 2015;175(1):18-25. (Scopus Equivalence A*) DOI
  6. Zhang Y*, Baik S, Newhouse JP. Use of intelligent assignment to Medicare Part D plans for people with schizophrenia could produce substantial savings. Health Affairs. March 2015; 34 (3):455-460. PMC4349210. (Scopus Equivalence A*) DOI
  7. Driessen J, Steenrod J, Stevans J, James AE III, Minnier T, Reynolds B, Zhang Y. Innovative approaches to interprofessional care at the University of Pittsburgh Medical Center. Journal of Interprofessional Care. 2015;29(5):520-1. (Scopus Equivalence A) DOI

2014

  1. Kaplan CM, Zhang Y*. The January Effect: Medication Reinitiation among Medicare Part D Beneficiaries. Health Economics. 2014 Nov 14; 23 (11):1287-300. (ABDC ranked A*) DOI
  2. Hou Z, Chang J, Yue D, Fang H, Meng Q, Zhang Y. Determinants of willingness to pay for self-paid vaccines in China. Vaccine. 2014 Jul 31;32(35):4471-7. (Scopus Equivalence A*) DOI
  3. Zhang Y*, Zhou C, Baik SH. A simple change to the Medicare part d low-income subsidy program could save $5 billion. Health Affairs (Project Hope). 2014 Jun 1; 33 (6):940-5. (Scopus Equivalence A*) DOI
  4. Zhang Y*, Baik S. Race/ethnicity, Disability, and Medication Adherence Among Medicare Beneficiaries with Heart Failure. Journal of general internal medicine. 2014 Apr; 29 (4):602-7. (Scopus Equivalence A) PDF
  5. Zhang Y*, Kaplan CM, Baik SH, Chang CC, Lave JR. Medication adherence and readmission after myocardial infarction in the Medicare population. The American Journal of Managed Care. 2014; 20 (11):e498-505. (Scopus Equivalence B) PMC

2013

  1. Zhang Y*, Wu SH, Fendrick AM, Baicker K. Variation in medication adherence in heart failure. JAMA Internal Medicine. 2013 Mar 25; 173 (6):468-70. (Scopus Equivalence A*) DOI
  2. Smith KJ, Baik SH, Reynolds CF 3rd, Rollman BL, Zhang Y*. Cost-effectiveness of Medicare drug plans in schizophrenia and bipolar disorder. The American journal of managed care. 2013 Feb; 19 (2):e55-63. (Scopus Equivalence B) Link
  3. Zhang Y*, Baik SH, Lave JR. Effects of Medicare Part D Coverage Gap on Medication Adherence. American Journal of Managed Care. 2013; 19 (6):e214-24. PMC3711553. (Scopus Equivalence B) PDF

2012

  1. Kaplan C, Zhang Y*. Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population. The journal of mental health policy and economics. 2012 Dec; 15 (4):171-8. (Scopus Equivalence B) PMC
  2. Zhang Y*, Baik SH, Fendrick AM, Baicker K. Comparing local and regional variation in health care spending. The New England journal of medicine. 2012 Nov; 367 (18):1724-31. (Scopus Equivalence A*) PDF
  3. Zhang Y*, Steinman MA, Kaplan CM. Geographic variation in outpatient antibiotic prescribing among older adults. JAMA Internal Medicine (formerly Archives of internal medicine). 2012 Oct 22; 172 (19):1465-71. (Scopus Equivalence A*) DOI
  4. Zhang Y*, Gellad WF, Zhou L, Lin YJ, Lave JR. Access to and use of $4 generic programs in Medicare. Journal of General Internal Medicine. 2012 Oct; 27 (10):1251-7. PMC3445678. (Scopus Equivalence A) PDF
  5. Zhou C, Zhang Y. The vast majority of Medicare Part D beneficiaries still don’t choose the cheapest plans that meet their medication needs. Health affairs (Project Hope). 2012 Oct; 31 (10):2259-65. (Scopus Equivalence A*) DOI
  6. Baik SH, Rollman BL, Reynolds CF 3rd, Lave JR, Smith KJ, Zhang Y*. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure. The Journal of Mental Health Policy and Economics. 2012 Sep; 15 (3):105-18. (Scopus Equivalence B) PMC
  7. Zhang Y*, Baik SH, Chang CC, Kaplan CM, Lave JR. Disability, race/ethnicity, and medication adherence among Medicare myocardial infarction survivors. American Heart Journal. 2012 Sep; 164 (3):425-433.e4. (Scopus Equivalence A) DOI
  8. Zhang Y*, Baik SH, Zhou L, Reynolds CF, Lave JR. Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression. JAMA Psychiatry (formerly Archives of General Psychiatry). 2012 Jul; 69 (7): 672-9. (Scopus Equivalence A*) DOI
  9. Gellad WF, Donohue JM, Zhao X, Zhang Y, Banthin JS. The financial burden from prescription drugs has declined recently for the nonelderly, although it is still high for many. Health affairs (Project Hope). 2012 Feb; 31 (2):408-16. (Scopus Equivalence A*) DOI

2011

  1. Zhang Y*, Donohue JM, Lave JR, Gellad WF. The impact of Medicare Part D on medication treatment of hypertension. Health Services Research. 2011 Feb; 46:185-98. PMC3034269. (ABDC ranked A; InCites 5-year; ranked 20/88 in Health Care Sciences & Services) DOI
  2. Gellad WF, Huskamp HA, Li A, Zhang Y, Safran DG, Donohue JM. Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication. Journal of general internal medicine. 2011 Dec; 26 (12):1458-64. (Scopus Equivalence A) PDF
  3. Zhang Y*, Newhouse JP, Baicker K. Are Drugs Substitutes or Complements for Intensive (and Expensive) Medical Treatment? American Economic Review. 2011 May; 101 (3):393-97 DOI
  4. Zhang Y*, Zhou L, Gellad WF. Potential savings from greater use of $4 generic drugs. JAMA Internal Medicine (formerly Arch Intern Med) 15 Mar 2011; 171(5): 468-9. (Scopus Equivalence A*; ) DOI
  5. Lave JR, Men A, Day BT, Wang W, Zhang Y. Employee choice of a high-deductible health plan across multiple employers. Health services research. 2011 Feb; 46:138-54. (ABDC ranked A; Scopus Equivalence A) DOI
  6. Lu CY, Adams AS, Ross-Degnan D, Zhang F, Zhang Y, Salzman C, Soumerai SB. Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorder. Psychiatric services (Washington, D.C.). 2011 Feb; 62 (2):186-93. (Scopus Equivalence A) PDF
  7. Donohue JM, Zhang Y, Aiju M, Perera S, Lave JR, Hanlon JT, Reynolds CF 3rd. Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry. 2011 Dec; 19 (12):989-97. PMC3233981. (Scopus Equivalence A*) DOI

2010

  1. Zhang Y*, Baicker K, Newhouse JP. Geographic variation in the quality of prescribing. The New England journal of medicine. 2010 Nov 18; 363 (21):1985-8. (Scopus Equivalence A*) DOI
  2. Zhang Y*, Lee BY, Donohue JM. Ambulatory antibiotic use and prescription drug coverage in older adults. JAMA Internal Medicine (formerly Archives of internal medicine). 2010 Aug 9; 170 (15):1308-14. (Scopus Equivalence A*) DOI
  3. Zhang Y*, Baicker K, Newhouse JP. Geographic variation in Medicare drug spending. The New England journal of medicine. 2010 Jul 29; 363 (5):405-9. (Scopus Equivalence A*) DOI
  4. Zhang Y*, Lave JR, Newhouse JP, Donohue JM. How the Medicare Part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries. The journals of gerontology. Series B, Psychological sciences and social sciences. 2010 Jul; 65 (4):502-7. PMC2883868. (Scopus Equivalence A*) DOI
  5. Donohue JM, Zhang Y, Lave JR, Gellad WF, Men A, Perera S, Hanlon JT. The Medicare drug benefit (Part D) and treatment of heart failure in older adults. American heart journal. 2010 Jul; 160 (1):159-65. PMC2898511. (Scopus Equivalence A) DOI
  6. Zhang Y*, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Medical care. 2010 May; 48 (5):409-17. (Scopus Equivalence A) DOI

2009

  1. Zhang Y*, Donohue JM, Lave JR, O’Donnell G, Newhouse JP. The effect of Medicare Part D on drug and medical spending. The New England journal of medicine. 2009 Jul 2; 361 (1):52-61. (Scopus Equivalence A*) DOI
  2. Zhang Y*, Donohue JM, Newhouse JP, Lave JR. The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health affairs (Project Hope). 2009; 28 (2):w317-25. (Scopus Equivalence A*) DOI
  3. Zhang Y, Adams AS, Ross-Degnan D, Zhang F, Soumerai SB. Effects of prior authorization on medication discontinuation among Medicaid beneficiaries with bipolar disorder. Psychiatric services (Washington, D.C.). 2009 Apr; 60 (4):520-7. (Scopus Equivalence A) PDF

2008

  1. Zhang Y*. Cost-saving effects of olanzapine as long-term treatment for bipolar disorder. The journal of mental health policy and economics. 2008 Sep; 11 (3):135-46. (Scopus Equivalence B) PubMed

2007

  1. Zhang Y*, Soumerai SB. Do newer prescription drugs pay for themselves? A reassessment of the evidence. Health affairs (Project Hope). 2007; 26 (3):880-6. (Scopus Equivalence A*) DOI

2005

  1. Huskamp HA, Frank RG, McGuigan K, Zhang Y. The Impact of A Three-Tier Formulary on Demand Response for Prescription Drugs. Journal of Economics and Management Strategy. 2005; 14 (3):729-753. (Scopus Equivalence B) DOI